Practical Guidelines for Clinical Research and Drug Development
Cardiac Safety of Noncardiac Drugs > Application of ELectrocardiology in Clinical Research > 189-203
Cardiac Safety of Noncardiac Drugs > Application of ELectrocardiology in Clinical Research > 205-222
Cardiac Safety of Noncardiac Drugs > Application of ELectrocardiology in Clinical Research > 223-227
Cardiac Safety of Noncardiac Drugs > Application of ELectrocardiology in Clinical Research > 229-237
Cardiac Safety of Noncardiac Drugs > Application of ELectrocardiology in Clinical Research > 239-257
Cardiac Safety of Noncardiac Drugs > Application of ELectrocardiology in Clinical Research > 259-298
Cardiac Safety of Noncardiac Drugs > Clinical Methodologies and Technical Aspects of Assessing Cardiac Safety of Investigational Drugs: Focus on Cardiac Repolarization > 107-129
Cardiac Safety of Noncardiac Drugs > Clinical Methodologies and Technical Aspects of Assessing Cardiac Safety of Investigational Drugs: Focus on Cardiac Repolarization > 131-145
Cardiac Safety of Noncardiac Drugs > Clinical Methodologies and Technical Aspects of Assessing Cardiac Safety of Investigational Drugs: Focus on Cardiac Repolarization > 147-166
Cardiac Safety of Noncardiac Drugs > Clinical Methodologies and Technical Aspects of Assessing Cardiac Safety of Investigational Drugs: Focus on Cardiac Repolarization > 167-185
Cardiac Safety of Noncardiac Drugs > Preclinical and Pharmacogenomic Cardiac Safety Evaluations > 13-36
Cardiac Safety of Noncardiac Drugs > Preclinical and Pharmacogenomic Cardiac Safety Evaluations > 37-66
Cardiac Safety of Noncardiac Drugs > Preclinical and Pharmacogenomic Cardiac Safety Evaluations > 67-81
Cardiac Safety of Noncardiac Drugs > Preclinical and Pharmacogenomic Cardiac Safety Evaluations > 83-103